Charles Schwab
KALA icon

Charles Schwab’s KALA BIO KALA Stock Holding History

Charles Schwab’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-45
Closed -$156K – 3597
2022
Q1 		$156K Sell
45
-3
-6% -$7.86K ﹤0.01% 3346
2021
Q4 		$144K Hold
48
– – ﹤0.01% 3405
2021
Q3 		$312K Hold
48
– – ﹤0.01% 3259
2021
Q2 		$631K Buy
48
+7
+17% +$110K ﹤0.01% 3090
2021
Q1 		$693K Buy
41
+1
+3% +$19.5K ﹤0.01% 2972
2020
Q4 		$675K Hold
40
– – ﹤0.01% 2895
2020
Q3 		$747K Sell
40
-1
-2% -$23K ﹤0.01% 2757
2020
Q2 		$1.07M Buy
41
+18
+78% +$510K ﹤0.01% 2605
2020
Q1 		$495K Buy
23
+2
+10% +$32K ﹤0.01% 2718
2019
Q4 		$190K Hold
21
– – ﹤0.01% 3043
2019
Q3 		$196K Hold
21
– – ﹤0.01% 3040
2019
Q2 		$328K Buy
21
+6
+40% +$99.4K ﹤0.01% 2982
2019
Q1 		$316K Hold
15
– – ﹤0.01% 2927
2018
Q4 		$187K Buy
15
+6
+67% +$104K ﹤0.01% 3025
2018
Q3 		$232K Buy
9
+1
+13% +$30.5K ﹤0.01% 3051
2018
Q2 		$264K Sell
8
-2
-20% -$76.7K ﹤0.01% 3015
2018
Q1 		$404K Buy
10
+5
+100% +$190K ﹤0.01% 2789
2017
Q4 		$254K Hold
5
– – ﹤0.01% 2928
2017
Q3 		$313K Buy
+5
New +$274K ﹤0.01% 2859

Other funds holding KALA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Charles Schwab's KALA Position: Q2 2022 in Review

Charles Schwab sold out of KALA BIO (KALA) in Q2 2022, closing a stake of 45 shares — an estimated $156K sold.

Charles Schwab first reported a position in KALA in Q3 2017 and held it in 19 quarters. The position peaked at $1.07M in Q2 2020. 63 funds tracked by Wall St. Rank hold KALA as of Q2 2022.

  • Charles Schwab reported no remaining KALA BIO position as of Q2 2022 after selling out during the quarter.
  • Charles Schwab sold 45 KALA BIO shares in Q2 2022, an estimated $156K.
  • Charles Schwab first reported a position in KALA BIO in Q3 2017 and held it in 19 quarters.
  • Charles Schwab's KALA BIO position peaked at $1.07M in Q2 2020.
  • 63 funds tracked by Wall St. Rank held KALA BIO as of Q2 2022.

Based on Charles Schwab's 13F filing for Q2 2022, filed 15 Aug 2022.